<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03410134</url>
  </required_header>
  <id_info>
    <org_study_id>Irreversible pulpitis</org_study_id>
    <nct_id>NCT03410134</nct_id>
  </id_info>
  <brief_title>Assessment of Vital Pulp Therapy in Permanent Molars</brief_title>
  <official_title>Clinical Evaluation of Vital Pulp Therapy in Young Permanent Molars With Irreversible Pulpitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the long term clinical performance of vital pulp&#xD;
      therapy of young permanent teeth with irreversible pulpitis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Permanent molar teeth meeting the inclusion criteria will be included into the study.&#xD;
      Following local anaesthesia and dental dam application, caries excavation will be performed;&#xD;
      and after exposure, the pulp will be amputated to the level of the canal orifices (full&#xD;
      pulpotomy) using a sterile high-speed round bur under water coolant. After haemostasis is&#xD;
      achieved, Mineral trioxide aggregate (MTA) will be gently placed over the pulp to a thickness&#xD;
      of 2-3 mm and the tooth will be restored using glass ionomer cement and composite resin. A&#xD;
      postoperative periapical radiograph will be taken. Patients will be reviewed at 6., 12., 24.&#xD;
      and 36. months for clinical and radiographical success. The data will be analysed&#xD;
      statistically using chi square test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">August 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical evaluation of vital pulp therapy in permanent teeth with irreversible pulpitis</measure>
    <time_frame>3 years</time_frame>
    <description>Long-term success of vital pulp therapy in young permanent teeth with irreversible pulpitis. Evaluation criteria will be;&#xD;
spontaneous pain (absent/present);&#xD;
tenderness to percussion/palpation (absent/present);&#xD;
mobility (no mobility/ 1mm/ 2mm/ 3mm mobility)&#xD;
swelling (absent/present);&#xD;
fistula (absent/present)&#xD;
periapical/interradicular radiolucency (absent/present);&#xD;
widened periodontal ligament (absent/present);&#xD;
loss of lamina dura (absent/present);&#xD;
internal/external root resorption (absent/present).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Dental Caries Extending to Pulp</condition>
  <condition>Pulp Disease, Dental</condition>
  <arm_group>
    <arm_group_label>NeoMTA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vital pulp therapy with NeoMTA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NeoMTA</intervention_name>
    <description>NeoMTA™ Plus® root and pulp treatment material is a powder/gel system with no resin. The components are an extremely fine powder primarily tricalcium and dicalcium silicate plus a water-based gel.</description>
    <arm_group_label>NeoMTA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients and parents of the patients who accept to participate and sign the informed&#xD;
             consent&#xD;
&#xD;
          -  Patients who have at least one vital permanent molar teeth with irreversible pulpitis&#xD;
             symptoms&#xD;
&#xD;
          -  Teeth which can be restorable after the treatment.&#xD;
&#xD;
          -  Teeth which has good periodontal health and in the absence of sinus tracts or&#xD;
             swelling.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients and parents of the patients who does not accept to participate and sign the&#xD;
             informed consent&#xD;
&#xD;
          -  Teeth which have dentoalveolar or extraoral swelling&#xD;
&#xD;
          -  Teeth which have periodontal disease, mobility or alveolar bone loss&#xD;
&#xD;
          -  Teeth which are not restorable&#xD;
&#xD;
          -  Patients who are not cooperative with the treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zafer C Cehreli, DDS,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zafer C Cehreli, Prof</last_name>
    <phone>00905353197969</phone>
    <email>zcehreli@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gizem E Unverdi</last_name>
    <phone>00905052805736</phone>
    <email>erbasgizem@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hacettepe University</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zafer C Cehreli, DDS, PhD</last_name>
      <phone>+903123052289</phone>
      <email>zcehreli@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Beste Ozgur, DDS, PhD</last_name>
      <phone>+903123052280</phone>
      <email>besteisbitiren@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Zafer C Cehreli, DDS, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gizem Erbas Unverdi, DDS, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beste Ozgur, DDS, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Atilla S Atac, DDS, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Asgary S, Eghbal MJ, Ghoddusi J, Yazdani S. One-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter, randomized, non-inferiority clinical trial. Clin Oral Investig. 2013 Mar;17(2):431-9. doi: 10.1007/s00784-012-0712-6. Epub 2012 Mar 21.</citation>
    <PMID>22431145</PMID>
  </reference>
  <reference>
    <citation>Taha NA, Ahmad MB, Ghanim A. Assessment of Mineral Trioxide Aggregate pulpotomy in mature permanent teeth with carious exposures. Int Endod J. 2017 Feb;50(2):117-125. doi: 10.1111/iej.12605. Epub 2016 Jan 30.</citation>
    <PMID>26715408</PMID>
  </reference>
  <reference>
    <citation>Qudeimat MA, Alyahya A, Hasan AA. Mineral trioxide aggregate pulpotomy for permanent molars with clinical signs indicative of irreversible pulpitis: a preliminary study. Int Endod J. 2017 Feb;50(2):126-134. doi: 10.1111/iej.12614. Epub 2016 Feb 22.</citation>
    <PMID>26841969</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 3, 2017</study_first_submitted>
  <study_first_submitted_qc>January 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2018</study_first_posted>
  <last_update_submitted>March 12, 2021</last_update_submitted>
  <last_update_submitted_qc>March 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>Zafer Cavit Cehreli, DDS, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Permanent teeth</keyword>
  <keyword>Vital pulp therapy</keyword>
  <keyword>MTA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Caries</mesh_term>
    <mesh_term>Dental Pulp Diseases</mesh_term>
    <mesh_term>Stomatognathic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

